![Po Wen Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Po Wen Wu
Directeur Général chez
Polaris Pharmaceuticals, Inc.
Profil
Po Wen Wu is currently the President & Chief Executive Officer at Polaris Pharmaceuticals, Inc. and the Chairman & Chief Executive Officer at Designerx Pharmaceuticals, Inc. He is also the Chief Executive Officer & Director at DRX USA, DRX Chengdu, and TDW Pharmaceuticals, Inc. Additionally, he serves as a Director at DesigneRx Europe Ltd., DRX SHANGHAI, and DRX Hong Kong.
In the past, he was the President & Chief Executive Officer at Polaris Group, Inc. from 2011 to 2013 and the Chairman & General Manager at Polaris Group.
Dr. Wu holds a doctorate degree from the University of California, Berkeley.
Postes actifs de Po Wen Wu
| Sociétés | Poste | Début |
|---|---|---|
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Researches and develops protein drugs for cancer treatment | Directeur Général | - |
DesigneRx Europe Ltd. | Directeur/Membre du Conseil | - |
Designerx Pharmaceuticals, Inc.
 Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu. | Directeur Général | - |
DRX USA | Directeur Général | - |
TDW Pharmaceuticals, Inc. | Directeur Général | - |
DRX Chengdu | Directeur Général | - |
DRX SHANGHAI | Directeur/Membre du Conseil | - |
DRX Hong Kong | Directeur/Membre du Conseil | - |
Anciens postes connus de Po Wen Wu
| Sociétés | Poste | Fin |
|---|---|---|
Polaris Group, Inc.
 Polaris Group, Inc. Real Estate DevelopmentFinance Offers real estate sales, marketing & consulting services | President | 06/03/2013 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Po Wen Wu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Polaris Group, Inc.
Polaris Group, Inc. Real Estate DevelopmentFinance Offers real estate sales, marketing & consulting services | Finance |
Polaris Pharmaceuticals, Inc.
Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Researches and develops protein drugs for cancer treatment | Health Technology |
TDW Pharmaceuticals, Inc. | |
Polaris Group
 Polaris Group BiotechnologyHealth Technology Engages in research and development of protein drugs to treat cancer and other debilitating diseases in humans | Health Technology |
DesigneRx Europe Ltd. | |
Designerx Pharmaceuticals, Inc.
Designerx Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Part of Polaris Group, Designerx Pharmaceuticals, Inc. is a multinational biotechnology company that specializes in the development of novel anti-cancer therapies. The company is based in Vacaville, CA. The company's lead drug candidate, Pegargiminase (Adi-Peg 20), is a biologic in late-stage clinical development for a variety of cancers. The CEO of the company is Po Wen Wu. | Health Technology |
DRX USA | |
DRX Chengdu | |
DRX SHANGHAI | |
DRX Hong Kong |
